Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia

Molecular Genetics and Metabolism

Volumn 93, Issue 4, 2008, Pages 444-449

  Arnoux, J B ^a   Boddaert, N ^a   Valayannopoulos, V ^a   Romano, S ^a   Bahi Buisson, N ^a   Desguerre, I ^a   de Keyzer, Y ^a   Munnich, A ^a   Brunelle, F ^a   Seta, N ^b   Dautzenberg, M D ^a   de Lonlay, P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Congenital disorder of glycosylation type Ia (CDG Ia); Hemostasis; Stroke; Stroke like

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ANTITHROMBIN; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; GLYCOPROTEIN; PROTEIN C;

ANTIGENICITY; ARTICLE; BLEEDING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1A; CYTOLYSIS; FEMALE; FEVER; HEMOSTASIS; HUMAN; IMMOBILIZATION; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; THROMBOSIS;

ADOLESCENT; CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOSYLATION; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PHOSPHOTRANSFERASES (PHOSPHOMUTASES); RISK ASSESSMENT; STROKE; THROMBOSIS;

EID: 40849142196     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.11.006     Document Type: Article

References (35)

1. Jaeken J., Vanderschueren-lodeweyckx M., Casaer P., Snoek L., and Corbeel L. Pediatr. Res. 14 (1980) 179
2. de Lonlay P., Seta N., Barrot S., Chabrol B., and Drouin V. A broad spectrum of clinical presentations in Congenital disorder of glycosylation I: a series of 26 cases. J. Med. Genet. 38 (2001) 14-19
3. Nordborg C., Hagberg B., and Kristiansson B. Sural nerve pathology in the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr. Scand. Suppl. 375 (1991) 39-49
4. Imitiaz F., Worthington V., Champion M., Beesley C., and Charlwood J. Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type. J. Inherit. Metab. Dis. 23 (2000) 162-174
5. Van Ommen C.H., Peters M., Barth P.G., Vreken P., and Wanders R.J.A. Carbohydrate-deficient glycoprotein syndrome type 1a: a variant phenotype with borderline cognitive dysfunction, cerebellar hypoplasia, and coagulation disturbances. J. Pediatr. 136 (2000) 491-495
6. Jaeken J., Hagberg B., and Stromme P. Clinical presentation and natural course of the CDGS. Acta Paediatr. Scand. Suppl. 375 (1991) 6-13
7. Miossec-Chauvet E., Mikaeloff Y., Heron D., Merzoug V., Cormier-Daire V., de Lonlay P., et al. Neurological presentation in pediatric patients with Congenital Disorder of Glycosylation type 1a. Neuropediatrics 34 (2003) 1-6
8. Pearl P.L., and Krasnewich D. Neurological course of CDG. J. Child Neurol. 16 (2001) 409-413
9. Jaeken J., and Casaer P. Carbohydrate-deficient glycoconjugate (CDG) syndrome: an new chapter of neuropaediatrics. Eur. J. Paediatr. Neurol. 2/3 (1997) 61-66
10. Blennow G., Jaeken J., and Wiklund L.M. Neurological findings in the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr. Scand. Suppl. 375 (1991) 14-20
11. Drouin-Garraud M. Neurological presentation of CDGS-1a: implication for diagnosis and genetic counselling. Am. J. Med. Genet. 101 (2001) 46-49
12. Stromland K., Hagberg B., and Kristianson B. Ocular pathology in disialotransferrin developmental deficiency syndrome. Ophtal. Paediat. Genet. 11 (1990) 309-313
13. Andreasson S., Blennow G., Ehinger B., and Stromland K. Full filed electroretinogrammes in patients with carbohydrate-deficient glycoprotein syndrome. Am. J. Ophtal. 112 (1991) 83-89
14. Akaboshi S., Ohno K., and Takeshita K. Neuroradiological findings in the carbohydrate-deficient glycoprotein syndrome. Neuroradiology 37 (1995) 491-495
15. Stibler H., Holzbach U., Tengborn L., and Kristiansson B. Complex functional and structural coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome type 1. Blood Coag. Fibrin 7 (1996) 118-126
16. Fiumara A., Barone R., Buttitta P., Musso R., and Pavone L. Haemostatic studies in carbohydrate-deficient glycoprotein syndrome type 1. Thromb. Haemost. 76 4 (1996) 502-504
17. Okamoto N., Wada Y., Kobayashi M., Otani K., and Tagawa T. Decreased blood coagulation activities in carbohydrate-deficient glycoprotein syndrome. J. Inherited Metab. Dis. 16 (1993) 435-440
18. Ijima K., Murakami F., Nakamura K., Ikawa S., and Yuasa I. Hemostatic studies in patients with carbohydrate-deficient glycoprotein syndrome. Thromb. Res. 76 2 (1994) 193-198
19. Young G., and Driscoll C. Coagulation abnormalities in the carbohydrate-deficient Glycoprotein syndrome: case report and review of the literature. Am. J. Hematol. 60 (1999) 66-69
20. Van Geet C., and Jaeken J. A unique pattern of coagulation abnormalities in carbohydrate-deficient glycoprotein syndrome. Pediatr. Res. 33 5 (1993) 540-541
21. Funk M., Becker S., Potzsch B., Kreuz W., and Bohles H. Thrombophilia in a child with CDG-syndrome type I. Thromb. Haemost. 74 4 (1995) 1199-1200
22. Petersen M.B., Brostrom K., Stibler H., and Skovby F. Early manifestation of the carbohydrate-deficient glycoprotein syndrome. J. Pediatr. 122 1 (1993) 66-70
23. Briones P., Vilaseca M.A., Garcia-Silva M.T., Pineda M., and Colomer J. Congenital disorder of glycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease. Eur. J. Paediatr. Neurol. 5 (2001) 127-131
24. Stibler H., Blennow G., Kristiansson B., Lindehammer H., and Hagberg B. Carbohydrate-deficient glycoprotein syndrome: clinical expression in adult with a new metabolic disease. J. Neurol. Neurosurg. Psychiatry 57 5 (1994) 552-556
25. Stromme P., Maehlen J., Strom E.H., and Torvik A. Postmortem findings in two patients with the carbohydrate-deficient Glycoprotein syndrome. Acta Paediatr. Scand. Suppl. 375 (1991) 55-62
26. Bruin T., Sturk A., Ten Cate J.W., and Cath M. The function of the human factor V carbohydrate moiety in blood coagulation. Eur. J. Biochem. 170 1-2 (1987) 305-310
27. Grinnel B.W., Walls J.B., and Gerlitz B. Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. J. Biol. Chem. 266 (1991) 9778-9785
28. van Hylckama Vlieg A., van der Linden I.K., Bertina R.M., and Rosendaal F.R. High levels of factor IX increase the risk of venous thrombosis. Blood 95 12 (2000) 3678-3682
29. Eichinger S., Schonauer V., Weltermann A., Minar E., Bialonczyk C., Hirschl M., et al. Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism. Blood 103 10 (2004) 3773-3776
30. Erkekol F.O., Ulu A., Numanoglu N., and Akar N. High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism. Respirology 11 1 (2006) 70-74
31. Amaral A., Opal S.M., and Vincent J.L. Coagulation in sepsis. Intensive Care Med. 30 6 (2004) 1032-1040
32. Levi M., de Jonge E., and van der Poll T. Sepsis and disseminated intravascular coagulation. J. Thromb. Thrombolysis 16 1-2 (2003) 43-47
33. Hesselvick J.F., Malm J., Dalhback B., and Blomback M. Protein C, protein S and C4B-binding protein in severe infection and septic shock. Thromb. Haemost. 65 2 (1991) 126-129
34. Fournier F., Jourdain M., Tournis A., Caron C., Goudemand J., and Chopin C. Coagulation inhibitor substitution during sepsis. Intensive Care Med. 21 S2 (1995) S264-S268
35. Van Geet C., Jaeken J., Freson K., Lenaerts T., Arnout J., Vermylen J., and Hoylaerts M.F. Congenital disorder of glycosylation type Ia and IIa are associated with different primary haemostatic complications. J. Inherit. Metab. Dis. 24 4 (2001) 477-492